MFT to launch data platform to support research and patient care

Manchester University NHS Foundation Trust (MFT) is launching a platform to give clinicians and approved teams easier access to data to support improvement, research and more informed care for patients.

The MDClone Ask, Discover, Act, Measure and Share (ADAMS) platform will go live in July 2026. Its synthetic data capability will reduce the need to use real patient data in many scenarios, supporting data safety and privacy.

Across the NHS, large volumes of data are generated, but it can still be difficult to access and use that information quickly enough to support improvement.

The platform will help teams move more quickly from question to insight and identify opportunities to improve quality, productivity and performance.

Professor David Walliker, chief digital and information officer at MFT, said: “The launch of the ADAMS platform is about giving our clinicians and teams better access to the data they need to improve care for patients.

“By making it easier for approved users to access and analyse data, it will help us identify opportunities to improve quality, productivity and performance more quickly and support faster research and innovation.

“The platform also strengthens our approach to data safety and privacy. ADAMS sits within MFT’s existing governance framework, keeping data under NHS control and access limited to authorised users.

“Its ability to generate high-fidelity synthetic data will reduce the need to use real patient data in many scenarios, providing an additional privacy-enhancing capability for improvement, research and collaboration.”

When the platform goes live next month, MFT’s first area of focus will be kidney disease. ADAMS will help the trust monitor patients’ progress, manage waiting lists and plan its kidney dialysis service across the organisation.

MDClone is a healthcare data and AI company that helps organisations use data more effectively for improvement, research and innovation.

On the launch of ADAMS at MFT, Bruno Lempernesse, chief executive at MDClone, said: “MFT is joining other leading hospitals around the world that are using data more effectively to improve care, strengthen research and support safer collaboration.

“We are proud to partner with an organisation with MFT’s ambition and leadership as it builds long-term capability through the ADAMS platform.”

In March 2026, MFT announced plans to expand the use of AI tools across its workforce.

Over the past 18 months, the trust has been working with Microsoft to explore how AI can support staff in their day-to-day work.

This has included deploying Dragon Copilot ambient voice technology to hundreds of clinicians and providing around 1,500 Microsoft 365 Copilot licences to staff.

The next phase will increase the number of staff with access to Copilot and establish an ‘Agent Factory’ at the trust, enabling teams to design and implement AI tools to automate routine operational tasks across services.